When was CareGlance founded?

CareGlance was founded in 2019 and raised its 1st funding round 4 years after it was founded.

Where is CareGlance located?

CareGlance is headquartered in Milano, Italy.

How many employees does CareGlance have?

As of Sep 30, 2026, the latest employee count at CareGlance is 12.

Is CareGlance a funded company?

CareGlance is a funded company, having raised a total of $4.36M across 2 funding rounds to date. The company's 1st funding round was a €***** Seed round, raised on Nov 07, 2023.

When was the latest funding round of CareGlance?

CareGlance's latest funding was a $***** Seed round on Apr 09, 2026, with participation from 3 investors.

Where does CareGlance rank among its competitors?

CareGlance ranks 16th amongst 72 active competitors, of which 29 are funded. It stands 8th in terms of total funding among its competitors. The most recent competitor to raise funding was DexForce Technology Co, which secured $147M in Jun, 2026.

Who are the top competitors of CareGlance?

CareGlance's top competitors include OncoRes Medical, Vivolight and DexForce Technology Co. Among them, DexForce Technology Co secured the most recent funding round in June, 2026.

CareGlance - 2026 Company Profile, Funding & Competitors

CareGlance is a seed company based in Milano (Italy), founded in 2019. It operates as a Developer of portable, real-time swept source OCT imaging systems. These systems utilize photonic devices for real-time monitoring in industrial applications. The technology enables portable imaging capabilities through photonic innovation. Development focuses on enhancing the performance and accessibility of swept source OCT technology for various industrial uses.. CareGlance has raised $4.36M in funding from CDP Venture Capital. The company has 72 active competitors, including 29 funded and 7 that have exited. Its top competitors include companies like OncoRes Medical, Vivolight and DexForce Technology Co.

Company Details

{}

Website: www.careglance-srl.it/
Phone Number: +39 **********

Key Metrics

Founded Year

2019

Location

Milano, Italy

Stage

Seed

Total Funding

$4.36M in 2 rounds

Latest Funding Round

Seed, Apr 09, 2026, $*****

Investors

CDP Venture Capital & 2 more

Ranked

16^th among 72 active competitors

Employee Count

12 as on Sep 30, 2026

Similar Companies

DexForce Technology Co & 50 more

View CareGlance's full profile

CareGlance has raised a total funding of $4.36M over 2 rounds. Its first funding round was on Nov 07, 2023. Its latest funding round was a Seed round on Apr 09, 2026 for $*****. 3 investors participated in its latest round. CareGlance has 3 institutional investors.

Here is the list of recent funding rounds of CareGlance:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Apr 09, 2026	3578822	Seed	8794721	2366695	5015933	8277162
Nov 07, 2023	4994189	Seed	9733497	2702084	6814727	LIFTT

Access funding benchmarks and valuations. Sign up today!

View details of CareGlance's funding rounds and investors

CareGlance's employee count trend

CareGlance has 12 employees as of Sep 26. Here is CareGlance's employee count trend over the years:

Uncover CareGlance's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of CareGlance include OncoRes Medical, Vivolight and DexForce Technology Co. Here is the list of Top 10 competitors of CareGlance, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	OncoRes Medical 2014, Perth (Australia), Series B	Developer of intraoperative imaging technology for surgical procedures	$33.1M	Australian Unity, Brandon BioCatalyst & 5 others	59/100
2nd	Vivolight 2012, Shenzhen (China), Seed	Developer of optical coherence tomography for coronary functional evaluation	$28.5M	Efung Capital, Guangzhou Industrial Investment Group ... & 13 others	58/100
3rd	DexForce Technology Co 2021, Shenzhen (China), Series B	Developer of embodied intelligence engine and humanoid robot platforms	$161M	NewMargin Ventures, Guiyang Digital Economy Fund ... & 12 others	56/100
4th	SpectraWAVE 2012, Waltham (United States), Acquired	Provider of diagnostic photonic imaging	$79.9M	Deerfield, Johnson & Johnson Innovation – JJDC ... & 6 others	56/100
5th	Santec Holdings 1979, Komaki (Japan), Public	Manufacturer of optical instruments, components, and imaging and sensing systems	-	HHS	55/100
6th	Vivosight 2006, Maidstone (United Kingdom), Series B	Provider of optical coherence tomography diagnostic device for dermatology	$8.9M	Smith+Nephew, The Secretary Of State For Energy and Industrial Strategy ... & 122 others	47/100
7th	iHealthScreen 2015, Richmond (United States), Funding Raised	AI-powered screening tools for early detection of retinal diseases	-	Design Technologies, HHS	47/100
8th	Michelson Diagnostics 2006, Maidstone (United Kingdom), Deadpooled	Point-of-care Optical Coherence Tomography(OCT) device for dermatology	$14.9M	Octopus Ventures, Octopus Investments & 79 others	46/100
9th	Guangjian Technology 2018, Shanghai (China), Series B	Provider of ToF and structured light-based cameras	$70.3M	SBCVC, Wu Capital & 6 others	46/100
10th	Intel RealSense 2005, Bengaluru (India), Unfunded	Manufacturer and provider of structured light 3D camera	-	-	45/100
16th	CareGlance 2019, Milano (Italy), Seed	Developer of portable, real-time swept source OCT imaging systems. These systems utilize photonic devices for real-time monitoring in industrial applications. The technology enables portable imaging capabilities through photonic innovation. Development focuses on enhancing the performance and accessibility of swept source OCT technology for various industrial uses.	$4.36M	CDP Venture Capital, LIFTT & 1 others	41/100